[1] Mi CG, Tang XM, Liu JQ, et al.Synthesis of phosphocreatine disodium[J]. Chinese Journal of Pharmaceuticals(中国医药工业杂志), 2013, 44(8): 741-743. [2] Guo C, Wang JZ, Jiang J.Brief analysis pharmaceutical research of creatine phosphate sodium[J]. China Medicine and Pharmacy(中国医药科学),2014, 4(17): 139-141. [3] Xia HJ, Tian QY, Xu WJ.Analysis of clinical rationality of sodium creatine phosphate in pediatrics[J]. Journal of Community Medicine(社区医学杂志), 2018, 5(1): 57-58. [4] Huo Y, Fu XH, Ge JB, et al.Guidelines for the rational use of thrombolytic therapy for acute ST-segment elevation myocardial infarction[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version)(中国医学前沿杂志, 2016, 8(8): 25-41. [5] Chen SB, Li WZ, Ma PR, et al.Diagnosis and treatment of heart failure in children[J]. Chinese Journal of Pediatrics(中华儿科杂志), 2006, 44(10): 753-757. [6] Committee of experts on rational drug use of national health commission of the P. R. China, Chinese Pharmacists Association. Guidelines for rational drug Use for coronary heart disease[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version)(中国医学前沿杂志), 2016, 8(6): 19-108. [7] Cao JY, Qu XJ, Qin Y, et al.Two case of Neonatal hypocalcemia induced by sodium phosphate for injection[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(5): 313-314. [8] Liu XW.One case of tachycardia allergy induced by sodium creatine phosphate for injection[J]. The Journal of Medical Theory and Practice(医学理论与实践), 2011,24(10):1195. [9] Li L, Yu QY.One case of anaphylactic shock induced by sodium creatine phosphate for injection[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2013(6): 575. [10] Cai HX, Zhao HW, Qin YH, et al.One case of headache induced by sodium creatine phosphate for injection[J]. Pharmaceutical and Clinical Research(药学与临床研究),2017, 25(4): 167. [11] Yan CM, Li L, Xie Y.One case of transient hypertension induced by sodium creatine phosphate for injection[J]. People’s Military Surgeon(人民军医), 2014, 57(7): 797. [12] The Ministry of Health of the People’s Republic of China. Provisions for adverse drug reaction reporting and monitoring[Z].2011-05-04. [13] Lu JM, Li Q, Li ZP.Anaphylactic cyanosis induced by intravenous infusion of sodium phosphocreatine in one 1-year-old female child[J]. Evaluation and Analysis of Drug-Use in Hospitals of China(中国医院用药评价与分析), 2019, 19(3): 381-383. [14] hen YX, Zhang K, Tian HM, et al. The regulation of FGF23 in phosphate homeostasis and its clinical significance[J].Chinese Journal of Osteoporosis and Bone Mineral Research(中华骨质疏松和骨矿盐疾病杂志), 2012, 5(3): 157-166. [15] Jiao Y, Ma JR, Liu WW.Clinical analysis of neonatal hypocalcemia related to creatine phosphate sodium via venous injection[J]. Chinese Journal of Clinical Pharmacy(中国临床药学杂志), 2016, 25(6): 370-373. [16] Wang D.Active surveillance of adverse drug reaction and its development trend[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(10): 600-602. |